Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 7.3B | 9.9B | 7.0B | 6.8B |
Cost of revenue | 5.9B | 6.3B | 5.2B | 5.0B |
Gross profit | 1.4B | 3.6B | 1.8B | 1.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 66M | 2.2B | 562M | 565M |
Non operating interest income | ||||
Income | 1M | 6M | 3M | 3M |
Expense | 1M | -3M | 9M | 2M |
Other income expense | — | — | — | — |
Pretax income | 58M | 2.2B | 560M | 614M |
Tax provision | -414M | 585M | 133M | 214M |
Net income | 473M | 1.7B | 427M | 400M |
Basic EPS | — | — | — | 30.1 |
Diluted EPS | — | — | — | 30.1 |
Basic average shares | — | — | — | 13.3M |
Diluted average shares | — | — | — | 13.3M |
EBITDA | 33M | 2.2B | 552M | 584M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |